Topic

Daniele D'Ambrosio

1 recent story · updated continuously

Businesswire

Alfasigma Reveals Promising Results of Filgotinib in Axial Spondyloarthritis at EULAR 2026

healthJust now
Alfasigma Reveals Promising Results of Filgotinib in Axial Spondyloarthritis at EULAR 2026